Chronic kidney disease is both a cause and consequence of hypertension (HTN), and both CKD and HTN are independent risk factors for cardiovascular disease (CVD). Thus CKD, CVD and HTN are closely inter-related, and the investigation of each in relation to the others holds the greatest promise for improving the public health. Clinical and translational research can advance understanding of these inter-relationships by evaluating the relevance of basic science discoveries to these conditions in humans, and by identifying associations in humans that warrant validation in biological systems. The Clinical and Translational Core of the Duke O'Brien Center for Kidney Research (DOCK) builds on an outstanding track record of human research in CKD, CVD and HTN. However, this research base has generally operated as 3 separate research agendas. The proposed Core will encourage and facilitate expansion of each area into multi-disciplinary research that addresses the thematic focus of DOCK: the kidney in hypertension and the unique links between the kidney and cardiovascular disease. The Core will capitalize on existing relationships of investigators in Duke Nephrology with the Duke Translational Medicine Institute (DTMI), the Duke Clinical Research Institute (DCRI), and other entities within DTMI. Core investigators will expand our understanding of mechanisms, translate and/or validate findings from the other Cores into human studies, and develop strategies for implementing effective interventions addressing our thematic area of focus. The proposed Clinical and Translational Core has four functional units: 1) a Study Implementation Group to provide oversight and project management;2) a Biostatistics Unit to provide support for study design, data analysis, and data management;3) a Biological Samples Unit to provide access to existing biological sample repositories;and 4) a Database Unit to provide access to existing clinical data repositories. These resources will provide foundational support for a wide range of clinical research approaches by a diverse, multidisciplinary group of clinical and translational investigators. This Core will foster collaboration and communication among Core investigators and across the other Cores within the DOCK, potentially leading to bi-directional translation of findings from clinic to bench and back. Thus the proposed Clinical and Translational Core will promote powerful interdisciplinary research that will move science forward in addressing the inter-relationships among CKD, CVD and HTN.

Public Health Relevance

Kidney disease, heart disease and high blood pressure are common conditions that exacerbate each other. The Clinical and Translational Core of the Duke O'Brien Center for Kidney Research will support human research, primarily through evaluation of data and biological samples collected in previous studies, to increase our understanding of the inter-relationships among these three conditions, research that will ultimately improve our ability to prevent and treat each of these conditions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK096493-02
Application #
8529527
Study Section
Special Emphasis Panel (ZDK1-GRB-6)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
2
Fiscal Year
2013
Total Cost
$328,281
Indirect Cost
$119,185
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
van Haaster, Marloes C; McDonough, Alicia A; Gurley, Susan B (2018) Blood pressure regulation by the angiotensin type 1 receptor in the proximal tubule. Curr Opin Nephrol Hypertens 27:1-7
Hershberger, Kathleen A; Abraham, Dennis M; Liu, Juan et al. (2018) Ablation of Sirtuin5 in the postnatal mouse heart results in protein succinylation and normal survival in response to chronic pressure overload. J Biol Chem 293:10630-10645
Zullig, Leah L; McCant, Felicia; Silberberg, Mina et al. (2018) Changing CHANGE: adaptations of an evidence-based telehealth cardiovascular disease risk reduction intervention. Transl Behav Med 8:225-232
Stanifer, John W; Landerman, Lawrence; Pieper, Carl F et al. (2018) Relations of established aging biomarkers (IL-6, D-dimer, s-VCAM) to glomerular filtration rate and mortality in community-dwelling elderly adults. Clin Kidney J 11:377-382
Wyatt, Christina M; Crowley, Steven D (2018) Intersection of salt- and immune-mediated mechanisms of hypertension in the gut microbiome. Kidney Int 93:532-534
Scialla, Julia J; Brown, Landon; Gurley, Susan et al. (2018) Metabolic Changes with Base-Loading in CKD. Clin J Am Soc Nephrol 13:1244-1246
Adeyemo, Adebowale; Esezobor, Christopher; Solarin, Adaobi et al. (2018) HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome. Am J Kidney Dis 71:399-406
Gurley, Susan B; Ghosh, Sujoy; Johnson, Stacy A et al. (2018) Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy. Diabetes 67:2096-2106
Chatterjee, Ranee; Davenport, Clemontina A; Raffield, Laura M et al. (2018) KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts. PLoS One 13:e0203213
Hall, Gentzon; Lane, Brandon M; Khan, Kamal et al. (2018) The Human FSGS-Causing ANLN R431C Mutation Induces Dysregulated PI3K/AKT/mTOR/Rac1 Signaling in Podocytes. J Am Soc Nephrol 29:2110-2122

Showing the most recent 10 out of 106 publications